Article Details

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Given Consensus Rating of "Buy" by Brokerages

Retrieved on: 2021-02-02 07:22:35

Tags for this article:

Click the tags to see associated articles and topics

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Given Consensus Rating of "Buy" by Brokerages. View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 115,800 shares of the biopharmaceutical company's stock worth $360,000 after purchasing an additional ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo